Register to find the perfect partner
Jinfo Blog

7th July 2010

By Joanna Ptolomey

Item

In the high risk world of drug development and biotechnology finding the right partner can make or break your project success. Pharmaceutical development is very rarely a single organisation approach, and there is no single academic department, pharmaceutical or biotech company that can go it alone for expertise or financially. Like matchmaking you need to make sure that you attract the right people via your profile and your requirements. But how does this work is drug development – what kind of information would attract partners? Thomson Reuters have developed a product that uses your pipeline information to attract partners? Not just any partner, but the right partner for your needs wherever you are in the world? Thomson Reuters (http://www.thomsonreuters.com/) believe that their product ‘The Outpartnering Registry’ (http://digbig.com/5bbxgq) will help organisations do just that. Creating partnerships between the expertise in academic institutions and industry is a key success factor in the development of pipeline drug projects. Essentially the Registry enables authorized users to share essential information about their company and pipeline data with potential partners. The Outpartnering Registry is free to all organisations with drugs in development. It allows organisations to • Indicate which of their programs and drugs are available for partnering and, optionally, what type of partnership they are seeking in which regions of the world • Add and update partnering contacts together with links to LinkedIn profiles • Display attendance at partnering conferences and increase networking opportunities The registry is available via the Thomson Pharma Partnering product – generally considered to be one of the best drug pipeline information products on the market. This product offers a comprehensive insight into drugs currently in development, the companies developing them, and their market potential. For each potential partner and drug profiled, you can learn financial details, research interests, areas of therapeutic and technology expertise as well as existing licensing agreements. With the rewards that come with successful drug developments, a key success factor is always that very basic of finding the right partners. Insight and intelligence into the pipeline of niche organizations in a highly competitive market is highly valuable. The decision making and risk analysis is helped very much these products.

« Blog